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Abstract 
Sertoli cell is the “nurse” in testes that regulates germ cell proliferation and differentiation. One 
Sertoli cell supports a certain number of germ cells during these processes. Thus, it is the 
determinant of male reproductive capability. Sertoli cells originate from the primitive gonads 
during embryonic stage and their proliferations continue throughout the pre-pubertal stage. The 
proliferation and final density of Sertoli cells in the testis are regulated by hormones and local 
factors through autocrine, paracrine as well as endocrine methods. In the concise minireview, the 
most recent progresses in the study of factors and signaling pathways that participate into 
regulating the proliferation and function of Sertoli cell were summarized.  
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Introduction 
Sertoli cells play a decisive role in the male sex determination during embryogenesis and 
spermatogenesis of adulthood [1]. A Sertoli cell can support the development of a group of germ 
cells that provide growth factors and physical support, and the number of Sertoli cells in the 
testes is closely related to testicular volume and sperm yield. Postnatal Sertoli cells undergo 
continuous proliferation and differentiation until puberty stops dividing and begins feeding the 
germ cells. Thus, the number of Sertoli cells directly determines the adult male fertility. 
Endocrine hormones such as Follicle-stimulating hormone (FSH), estrogen, thyroxine and other 
paracrine growth factors including Insulin-like growth factors I (IGF-I) and  Insulin-like growth 
factor II (IGF-II), Fibroblast growth factors (FGF), somatostatin C, activin, Transforming growth 
factor (TGF) and Interleukin (IL) 1, The proliferation is very important [2-6]. Glial-cell-derived 
neurotrophic factor (GDNF) proteins are members of the TGF-β superfamily protein, and their 
receptors GFRa1, RET and NCAM are expressed in testis, suggesting its involvement into 
testicular development and spermatogenesis [7-11]. Mouse testicular gene knockout, testicular 
specific overexpression as well as in vitro culture of spermatogonial stem cell (SSC) have 
demonstrated that a certain level of GDNF is necessary for the maintenance and proliferation of 
SSCs [12, 13]. Studies have further showed that GDNF and Follicle-stimulating hormone (FSH) 
can synergistically promote the proliferation of neonatal rat testicular Sertoli cells [14]; another 
study has also shown that GDNF itself can promote the embryonic development of mouse Sertoli 
cell proliferation [15].  
 
1. Origin and development of Sertoli cells 
Testes have two main functions: production of testosterone and formation of haploid 
germ cells (spermatogenesis)[1]. These functions are generally regulated by pituitary 
gonadotropin, which act on Leydig cells and seminiferous tubules that produce testosterone 
through luteinizing hormone (LH) and FSH, respectively through acting on interstitial tissues 
Sertoli cells. 
Sertoli cell was first reported by Enrico Setoli in 1865, which plays an important role in 
the process of spermatogenesis [1]. By forming the constituent components of the seminiferous 
tubules, completely differentiated Sertoli cells form a tight junction between adjacent cells 
(blood testicular barrier) to control the flow of nutrients and growth factors to haploid germ cells 
[1]. Therefore, the so-called blood-testicular barrier is not the isolation between blood and 
testicular tissues, but precise boundary formed between haploid and diploid germ cells. Thus, a 
well-functioning Sertoli cell provides suitable mitogen, differentiation factor and energy for the 
germ cells during development, while protecting them from harmful components and removal of 
the host's own immune system [1, 16]. It is clear that the number and quality of spermatozoa are 
determined by the number of functional Sertoli cells. Thus, the size of the testes is usually used 
as a measure of the number of Sertoli cells [1]. 
The appearance of embryonic Sertoli cells in primitive gonads marks the beginning of 
embryonic testicular development [16-20]. These cells express the Sry gene, thus determining the 
male sex of the gonads [21-23]. In the mouse gonads, the Sry gene began to be expressed in 
somatic cells from day 10.5 (10.5 dpc) after mating (these somatic cells eventually differentiate 
into Sertoli cells), reach to a peak at 11.5 dpc and disappeared in the gonad of 12.5 dpc [24-26]. 
Thus, the expression of the Sry gene in Sertoli cells during sex differentiation is only last for less 
than 48 hours [27]. The Sry gene is first expressed in the middle of the gonad and then expands 
into the beak and tail, and its expression in each cell lasts about 8 hours [25, 28-31]; the human 
Sry gene is expressed at probably 41th days after ovulation and reach to its peak at 44th day [32]. 
Compared with mice, the expression of human Sry gene after sex determination is very low and 
also expressed in adult Sertoli cells [33]. The Sry gene of the pig began to express at 23th day 
after mating, and the expression is down-regulated from day 35
th
 [34]. In sheep, the Sry gene can 
be detected after 23-44 days of mating [35]. The somatic cells expressing Sry gene are precursors 
of Sertoli cells and eventually differentiate into Sertoli cells. The progenitor Sertoli cells induce 
the development of testicular cells during the process of angiogenesis and development of 
testicular cord formation [36-40]; at the same time, it can induce the migration of muscle, 
endothelial and mesenchymal cells from the potential mesonephros to the gonadal [41, 42]. 
Sertoli cells provide signals for the formation of other cells, induce the differentiation of steroid 
precursor cells to form Leydig cells, promote germ cells into the mitotic resting period, leading 
to the removal of secondary renal tubular cells through apoptosis [18]. As the sole source of anti-
Mullerian hormone, Sertoli cells are responsible for inhibiting the development of intrinsic 
female genitalia [1]. 
Immature Sertoli cells are distinctly different from mature Sertoli cells, both 
morphologically and biochemical functions. In addition to Sertoli cells, immature seminiferous 
tubules contain only pericytes and germline stem cells, that is also different from that of adults 
[1]. Since the differentiation of germ cell has not yet begun in this period, so the seminiferous 
tubules are solid without lumen. Approaching to adolescence, Sertoli cells gradually extend and 
establish a close connection between the cells. These cells began to produce semen; seminiferous 
tubules also become a cavity tube. The pattern of protein expression has also changed in 
differentiated Sertoli cells and began to produce factors such as transferrin [43] and 
inflammatory cytokines IL-1a [44-50]. Immature Sertoli cells continue to divide, but their 
proliferative capacity decreases with adolescence, and Sertoli cells cease to proliferation upon 
the formation of tight junction [51].  
2. Function and quantity regulation of Sertoli cells in mouse testes 
2.1. Sertoli cell function 
The main function of Sertoli cells is to regulate spermatogenesis and to change the proportion of 
sperm production [52]. Specific functions of Sertoli cells include the provision of nutrients and 
support for germ cells, phagocytosis of degraded germ cells and debris, release of sperm and / or 
response to pituitary hormones to produce host proteins to regulate spermatogonial mitosis [16, 
53-59]. 
A typical feature of Sertoli cells providing structural support for germ cells at the developmental 
stage is the formation of a tightly connected blood testes barrier between adjacent cells [52]. This 
barrier isolates the spermatogonia and the pre-leptotene spermatocytes in the basal part, which 
allows the pre-leptotene spermatocytes pass through to the lumen and form spermatids and 
sperm cells in the luminal cavity[60-62]. This structure assembles the formation of an immune 
barrier to isolate the highly differentiated germ cells (spermatocytes and sperms) from the host 
immune system, so that it does not stimulate the production of autoimmune reactions [52]. 
In the testes of adult male, the number of Sertoli cells determines the volume of the testes and the 
number of sperm produced per day [17]. Despite the differences among different species, the 
number of germ cells the supported by one Sertoli cell are fixed [17, 63]. Only immature Sertoli 
cells have proliferative capacity, so the number of Sertoli cells in each testis has been determined 
before adulthood [17]. There is significant difference among species in terms of the proliferation 
period of Sertoli cells. The proliferation of Sertoli cells in rodent mainly occur in   embryonic 
and early stages after birth, however the proliferation macaque’s Sertoli cells occur mainly 
before puberty stage [17]. However, as more data are obtained from more species, it is now 
possible to reach a consensus on the proliferation of Sertoli cells that the proliferation of Sertili 
cells of all species occurs mainly in embryos or neonatal and adolescent stages [17, 64]. 
Proper function of Sertoli cell is clearly necessary for normal differentiation of germ 
cells[1]. However, although many Sertoli cells expressed proteins have been identified, the 
effects of these factors on germ cell development are not clear in most cases[1]. The most 
convincing example of a single factor produced by Sertoli cells that plays a vital role in 
spermatogenesis is stem cell factor (SCF). SCF is specifically produced by Sertoli cells and their 
receptor c-Kit is expressed on spermatogonia [1]. Although the destruction of SCF or its receptor 
in mice leads to the absence of germ cells in the testes, the implication of this finding in human 
testes is unclear [1, 65]. Although Sertoli cells can be isolated and cultured through enzymatic 
digestion of the extracellular matrix in vitro, it is difficult to isolate Sertoli cells in the adult 
testes by enzymatic digestion with the close connection between the cells and the changes in cell 
membrane structure during adolescence [1]. In vitro studies on Sertoli cell function are focused 
on the effects of different endocrine and paracrine factors on the expression and activity of 
certain proteins such as transferrin, aromatase, androgen receptor (AR) and lactate Hydrogenase 
(LDHC), etc. [1]. 
In general, testes play their function under the control of host genes and gene products. 
Many regulatory factors function through acting on Sertoli cells. Here are some of the major 
hormones and regulatory factors. 
 
2.2. Sertoli cell function and quantity regulation 
2.2.1 Endocrine regulation 
2.1.1.1 Follicle-Stimulating Hormone (FSH) 
FSH is known as the main endocrine hormone that regulates Sertoli cell function [1]. In 
testes, Sertoli cells are the only cells that express FSH receptors, and the combination of FSH 
and other factors is necessary for the proliferation of Sertoli cells [4, 66-68]. In addition, FSH 
stimulates aromatase activity and Sertoli cells to produce inhibin, lactic acid, transferrin and AR 
[69-72]. Individuals that lack functional FSH receptors have significantly smaller testis size than 
that in normal person; this is consistent with the observed decrease Sertoli cell numbers in FSH 
receptor deficient mice [73]. Despite the reproductive capacity of people lack of FSH receptors, 
the spermatogenesis is disordered (eg, oligozoopermia and teratozoopermia) [74]. 
2.1.1.2 Thyroid hormone and thyroid stimulating hormone (Thyroid Hormone and Thyroid-
Stimulating Hormone, TH and TSH) 
 A series of studies in experimental animals have shown that hypothyroidism leads to an 
extension of Sertoli cell proliferation, the differentiation of Sertoli cells was inhibited, Sertoli 
cell number and testicular volume were increased, and the number of spermatozoa was also 
increased [75, 76]. In contrast, high levels of T3 promote the differentiation of Sertoli cells, 
resulting in a smaller testis volume and a lower sperm count [1]. Although the effect of high 
levels of TSH has not been elucidated in details, previous study has shown that high levels of 
TSH interacted with FSH receptors [77]. Human hypothyroidism is associated with increased 
testicular volume (without puberty), which also indicates an increase in the number of Sertoli 
cells [78]. 
2.1.1. 3 Prolactin (PRL) 
A widely recognized fact is that, in both females and males, elevated levels of PRL 
inhibit gonadotropin secretion, thereby affecting reproductive capacity [1]. Sertoli cells express 
PRL receptors; PRL can stimulate the proliferation of Sertoli cells [79]. In rats and pigs, PRL 
promotes lactate secretion and protein synthesis [80]. In male mouse, specific destruction of PRL 
or its receptors has no effect on the reproductive capacity, suggesting that PRL does not play a 
major role in the maintenance of male reproductive health of male mice (for a review, see [81]). 
There is no report showing the relation of pathological changes of human testes with the 
mutations in PRL or its receptors. 
2.1.1. 4 Growth Hormone (GH) 
Convincing evidences have shown that systematically or locally produced GH and 
insulin-like growth factor (IGF) interferes with gonadal function [1]. Since Sertoli cells express 
GH receptors [82], systematic injection of GH into the boar increased the volume of Sertoli cells 
and promoted their maturation [83]. Failure to respond to GH response led to delayed sexual 
maturation but did not affect reproductive capacity [84]. In addition, the lack of GH might be 
associated with the development of smaller testes volumes; although this did not result in a 
decreased reproductive capacity, the number of Sertoli cells was reduced [85]. So far, no in vitro 
study has shown that these phenomena observed in vivo could reflect the physiological functions 
directly mediated by receptors on Sertoli cells. Although it has been reported that GH treatment 
with GH-free boys could lead to reduced testicular volume and functional damage to [86], other 
reports did not support this finding [87, 88]. 
2.3 paracrine regulation 
2.3.1 Testosterone 
Spermatogenesis relies on the presence of sufficient levels of intracellular testosterone 
[89]. AR is expressed by Sertoli cells but not germ cells [90], suggesting that androgen acts on 
the seminiferous tubules through the former. Recent gene knockout studies have shown that AR 
expression in Sertoli cells is necessary for the development of blood-testis barrier [91], meiosis, 
as well as normal development of germ cells after meiosis [92]. The expression level of AR in 
Sertoli cells is associated with its maturation[1]. Although the action of androgen on Sertoli cells 
can regulate its gene expression and proliferation [92-94], the importance of this effect on the 
early proliferation of Sertoli cells remains uncertain [92]. There have been reports of Sertoli cell 
tumors in patients with AR mutations in vivo [95], and Sertoli cells of these patients still 
exhibited immature properties even in the absence of tumors [96]. 
2.3.2 Estrogen  
The role of estrogen in testes has been controversial in recent years. It was known that 
exposing male individuals before birth to estrogen would negatively affect their subsequent 
reproductive capacity [97]. However, the presence of estrogen receptors in testicular cells 
suggests that estrogen may has its own physiological function in the testes [98, 99]. Immature 
Sertoli cells produce estrogen through their own aromatase [100], whereas Leydig cells and germ 
cells become estrogen sources in adult testes [101]. Sertoli cells express estrogen receptor-beta 
(ER-beta) throughout the maturation process. Thus, it may be possible to respond to estrogen 
very early stage [102]. Although there is no evidence showing the requirement of estrogen to 
exercise normal physiological functions for these cells, the function of male testes carrying 
nonfunctional estrogen receptors or aromatase is disrupted [103]. In addition, although male 
mice lacking functional aromatase activity have fertility at an early stage, they become infertile 
subsequently [104]. 
2.3.3 Growth Factors 
A variety of growth factors have been isolated from the testes, including FGF-1, FGF-2, 
IGF-I, IGF-II, TGF-a, activin A and EGF[1]. The receptors for most of these growth factors are 
expressed on Sertoli cells [105-111]. Some of these factors, such as FGF-1, FGF-2, IGF-I, IGF-II, 
TGF-a, activin A and EGF stimulate the proliferation of Sertoli cells [67, 112-119]; while many 
others affect Sertoli cell functions such as the production of aromatase and transferrin (for a 
review, see [120]). 
2.3.4 Inhibin B 
Under the stimulation of FSH, Sertoli cells produce and secrete hormone peptide inhibin 
B into the cycling system[1]. It is generally believed that inhibin B inhibits pituitary production 
through endocrine pathway FSH and no clear evidence showing inhibin B acts on Sertoli cells 
through autocrine pathways[1]. The inhibin B in human blood is maintained at a high level at 
early stage after birth and slowly decline to a stable detectable level and gradually increases 
again at pubertal stage[1]. Clinically, the presence and function of Sertoli cells in childhood can 
be judged by analyzing the level of inhibin B [1]. In contrast, the level of adult inhibin B depends 
on the presence of germ cells, so it can reflect the entire spermatogenesis process [117, 121-123]. 
2.3.5 Glial cell-derived neurotrophic factor (GDNF) 
As a member of the TGF-β superfamily, GDNF was first known for its ability to preserve 
and differentiate the primary dopaminergic neurons [124, 125]. It is also a potent growth factor 
for the culture of motor neurons in vitro [126-131]. Although the dopaminergic and spinal motor 
neurons were normal in GDNF
 -/- 
gene knockout mice, the development of kidneys were blocked 
and gastrointestinal couldn’t be innervated and finally died in perinatal period [132-135]; the 
reproductive capacity GDNF
 +/-
  mice was reduced and eventually led to infertility [12]. In rat 
testes, the number of Sertoli cells was established two weeks before birth, and the expression of 
GDNF in the testis was the highest during this period [51, 136]. The results of nuclease 
protection showed that the expression level of GDNF gradually increased with the testicular 
development and reached to the peak at 1 week after birth, and decreased gradually in 2-3 weeks 
after birth, with the lowest level in adult testis [14]. The expression of GDNF was detected in 
Sertoli cells and TM4 cell lines at mRNA level, indicating that GDNF in the testes might be 
produced by Sertoli cells [9]. 
Although Sertoli cells were normal in both GDNF
 +/-
 and testis-specific expression mice, 
it has been reported that GDNF and FSH could act cooperatively to promot the proliferation of 
Sertoli cells in rat testicular lumps from 6day old rat [14]; another report also shows that GDNF 
can promote the proliferation of mouse Sertoli cells during embryonic development [15]. 
However, the molecular mechanism and signal transduction pathway of GDNF-promoting 
Sertoli cell proliferation are not yet clear and need further study. 
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